Product Code: ETC044706 | Publication Date: Jun 2023 | Updated Date: Jan 2024 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
Malaysia has seen a steady growth in the sales of companion animal specialty drugs over the past few years. This is mainly due to the increasing awareness among pet owners about their pets` health and well-being, as well as increased spending on veterinary care services. Market research shows that the expenditure on pet healthcare products such as prescription medicines, nutraceuticals and supplements for companion animals is expected to grow at a CAGR of 5.2% during 2020-2026 in Malaysia. The increase in demand for these products can be attributed to factors like higher disposable income, rising trend towards nuclear families with single or no children, urbanization, increased availability of quality products from international brands and improved animal nutrition & health management solutions offered by leading pharmaceutical companies across Malaysia. Furthermore, various government initiatives such as tax exemption to encourage adoption of animals and veterinarians are likely to propel further market growth over the forecast period (2020-2026)
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malaysia Companion Animal Specialty Drugs Market Overview |
3.1 Malaysia Country Macro Economic Indicators |
3.2 Malaysia Companion Animal Specialty Drugs Market Revenues & Volume, 2020 & 2030F |
3.3 Malaysia Companion Animal Specialty Drugs Market - Industry Life Cycle |
3.4 Malaysia Companion Animal Specialty Drugs Market - Porter's Five Forces |
3.5 Malaysia Companion Animal Specialty Drugs Market Revenues & Volume Share, By Product Types, 2020 & 2030F |
3.6 Malaysia Companion Animal Specialty Drugs Market Revenues & Volume Share, By Distribution Channel, 2020 & 2030F |
4 Malaysia Companion Animal Specialty Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Malaysia Companion Animal Specialty Drugs Market Trends |
6 Malaysia Companion Animal Specialty Drugs Market, By Types |
6.1 Malaysia Companion Animal Specialty Drugs Market, By Product Types |
6.1.1 Overview and Analysis |
6.1.2 Malaysia Companion Animal Specialty Drugs Market Revenues & Volume, By Product Types, 2020-2030F |
6.1.3 Malaysia Companion Animal Specialty Drugs Market Revenues & Volume, By Anti-Inflammatory Drugs, 2020-2030F |
6.1.4 Malaysia Companion Animal Specialty Drugs Market Revenues & Volume, By Vaccines, 2020-2030F |
6.1.5 Malaysia Companion Animal Specialty Drugs Market Revenues & Volume, By Antibiotics, 2020-2030F |
6.1.6 Malaysia Companion Animal Specialty Drugs Market Revenues & Volume, By Animal Feed Additives, 2020-2030F |
6.1.7 Malaysia Companion Animal Specialty Drugs Market Revenues & Volume, By Parasiticides, 2020-2030F |
6.1.8 Malaysia Companion Animal Specialty Drugs Market Revenues & Volume, By Skin Care Products, 2020-2030F |
6.2 Malaysia Companion Animal Specialty Drugs Market, By Distribution Channel |
6.2.1 Overview and Analysis |
7 Malaysia Companion Animal Specialty Drugs Market Import-Export Trade Statistics |
7.1 Malaysia Companion Animal Specialty Drugs Market Export to Major Countries |
7.2 Malaysia Companion Animal Specialty Drugs Market Imports from Major Countries |
8 Malaysia Companion Animal Specialty Drugs Market Key Performance Indicators |
9 Malaysia Companion Animal Specialty Drugs Market - Opportunity Assessment |
9.1 Malaysia Companion Animal Specialty Drugs Market Opportunity Assessment, By Product Types, 2020 & 2030F |
9.2 Malaysia Companion Animal Specialty Drugs Market Opportunity Assessment, By Distribution Channel, 2020 & 2030F |
10 Malaysia Companion Animal Specialty Drugs Market - Competitive Landscape |
10.1 Malaysia Companion Animal Specialty Drugs Market Revenue Share, By Companies, 2023 |
10.2 Malaysia Companion Animal Specialty Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |